Stock Exchange & Press Releases 2023

Print Print this release
September 06, 2023

Bittium Respiro™ Home Sleep Apnea Test and Analysis Solution On Display At ERS Congress

Press release
Free for publication on September 6, 2023, at 13.00 p.m. (CEST +1)

Bittium Respiro™ Home Sleep Apnea Test and Analysis Solution On Display At ERS Congress

Oulu, Finland, September 6, 2023 – Bittium’s advanced Home Sleep Apnea Test and Analysis Solution Bittium Respiro™ will be on display at the European Respiratory Society (ERS) congress in Milan, Italy, on September 10-12, 2023. The event brings together respiratory experts from around the world to showcase the latest advances in respiratory medicine and science.

According to research, there are more than 936 million people in the world with sleep apnea [1]. Sleep apnea is an underdiagnosed disease, causing the number of patients to increase constantly [2]. Untreated sleep apnea can reduce the ability to work and worsen the quality of life. Sleep apnea is a serious illness, and if left untreated, it is associated with an array of adverse health consequences, including cardiovascular disease, metabolic disorders, diabetes, cognitive impairment, and depression.

Bittium Respiro™ is an end-to-end solution consisting of a measurement device, analysis software, tailored accessories, and a service platform. Bittium Respiro™ focuses on night-time polygraphy (PG level) measurement performed at home. This solution will record and analyze typical sleep-disordered breathing and it uses artificial intelligence to speed up the analysis work. Bittium Respiro™ pre-analyzes the data obtained from the home study and converts it into a visual and informative format. This solution optimizes the workflow of the clinical team in further analysis and diagnosis.

Bittium Respiro™ supports different sensor configurations, and it adapts to and supports varying measurement needs extensively. It is suitable for high-volume sleep clinics as well as for sleep researchers who may require a wider array of biosignals. The sensor configuration is modified with the help of accessories.

Bittium’s Medical Technologies team will be at stand V.05 at the event.

For more information about Bittium Respiro™, please visit or contact our sales at

To register for the event, please visit .

Further information:

Antti Näykki
Senior Vice President, Medical Technologies
Tel. +358 40 344 3507

Main media


In the field of healthcare technology, Bittium offers solutions for the measurement and monitoring of biosignals in the areas of cardiology, neurophysiology, and sports medicine. In addition, Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its 35-year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, and customized solutions based on its product platforms and R&D services. Net sales in 2022 were EUR 82.5 million and operating profit was EUR 0.3 million. Bittium is listed on Nasdaq Helsinki.

[1] Benjafield et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respiratory Medicine 2019.
[2] Motamedi et al. Obstructive Sleep Apnea: A Growing Problem. The Ochsner Journal 2009 Fall; 9(3): 149–153.

Attachment images
Bittium-Respiro-front Bittium-Respiro angled